Loomis, Sayles & Company’s Cardiovascular Systems, Inc. CSII Stock Holding History

Loomis, Sayles & Company’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-538,608	Closed	-$21M	–	952
2015 Q1	$21M	Sell	538,608 -36,767	-6%	-$1.27M	0.06%	317
2014 Q4	$17.3M	Buy	575,375 +38,539	+7%	+$1.1M	0.05%	377
2014 Q3	$12.7M	Sell	536,836 -14,201	-3%	-$404K	0.04%	450
2014 Q2	$17.2M	Buy	551,037 +98,117	+22%	+$2.83M	0.05%	401
2014 Q1	$14.4M	Buy	452,920 +81,214	+22%	+$2.68M	0.04%	442
2013 Q4	$12.7M	Buy	+371,706	New	+$10.8M	0.04%	460

Other funds holding CSII

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company's CSII Position: Q2 2015 in Review

Loomis, Sayles & Company sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2015, closing a stake of 538,608 shares — an estimated $21M sold.

Loomis, Sayles & Company first reported a position in CSII in Q4 2013 and held it in 6 quarters. The position peaked at $21M in Q1 2015. 138 funds tracked by Wall St. Rank hold CSII as of Q2 2015.

Loomis, Sayles & Company reported no remaining Cardiovascular Systems, Inc. position as of Q2 2015 after selling out during the quarter.
Loomis, Sayles & Company sold 538,608 Cardiovascular Systems, Inc. shares in Q2 2015, an estimated $21M.
Loomis, Sayles & Company first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 6 quarters.
Loomis, Sayles & Company's Cardiovascular Systems, Inc. position peaked at $21M in Q1 2015.
138 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2015.

Based on Loomis, Sayles & Company's 13F filing for Q2 2015, filed 14 Aug 2015.